Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-146149
Filing Date
2023-05-16
Accepted
2023-05-16 16:33:13
Documents
5
Effectiveness Date
2023-05-16

Document Format Files

Seq Description Document Type Size
1 S-8 d472514ds8.htm S-8 57303
2 EX-5.1 d472514dex51.htm EX-5.1 9768
3 EX-23.1 d472514dex231.htm EX-23.1 1515
4 EX-FILING FEES d472514dexfilingfees.htm EX-FILING FEES 15676
5 GRAPHIC g472514page10.jpg GRAPHIC 13447
  Complete submission text file 0001193125-23-146149.txt   104026
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271973 | Film No.: 23928073
SIC: 2835 In Vitro & In Vivo Diagnostic Substances